Kritika Singh
I am aligning my academic, research, philanthropic, and entrepreneurial paths to make a meaningful and continued impact on the way we fight emerging and existing diseases. Currently, I am a PhD Student jointly between the University of Oxford and the National Cancer Institute funded through the Rhodes Scholarship and the NIH Oxford-Cambridge Scholarship. Interested in chemical biology, bioengineering, and immunology.
Selected Speaking Engagements
-
Rhodes Trust Class of 2020 Going Down Dinner Speaker
-
2020 Graduate Kritika Singh's Commencement Speech
-
Malaria, Mosquitos, and Motivation | Kritika Singh | TEDxTJHSST - YouTube
Malaria is one of the oldest and deadliest known diseases in human history, but we have underestimated this disease for ages. Studies report that malaria is ...
-
From Magic Potions to Malaria Eradication | Kritika Singh | TEDxNortheasternU
TEDxNortheasternU 2018 Theme: Wait...why? www.tedxnortheasternu.com Kritika Singh Malaria is an issue that millions are battling worldwide. Even with a high degree of funding and research, sometimes a simple solution is all that’s needed to help the community. Kritika works to bring many different disciplines together and looks to educate the public about malaria through her non-profit work. She believes if we all care, are passionate, and work together, we can end malaria worldwide. Kritika studies Bioengineering at Northeastern University. For more information on Kritika, visit www.tedxnortheasternu.com/speakers Subscribe to our channel: https://www.youtube.com/channel/UCldXAEeoiA7yrkNChuw8UCg/featured Find us on social media: Facebook: http://www.facebook.com/tedxnortheasternu Instagram: http://www.instagram.com/tedxnortheasternu Twitter: http://www.twitter.com/tedxneu LinkedIn: http://www.linkedin.com/tedxnortheasternu Kritika, a Northeastern University bioengineering student, is aligning her academic, research, and philanthropic paths to make a positive and continued impact on the way we fight malaria today. Currently, she is researching at the Center for System’s Biology at Massachusetts General Hospital. Previously, she has researched malaria at the National Institute of Allergy and Infectious Diseases at the National Institute of Health, at the Harvard T.H. Chan School of Public Health and at Acetylon Pharmaceuticals. Kritika is also the founder and CEO of Malaria Free World Inc., a non-profit organization aimed at raising awareness about the malaria epidemic as well as funds for eradication efforts. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
-
STEM Symposium 2016
Sponsored by Science and Technology innovating companies in the Washington, DC area.
Selected Publications and Patents
-
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Blood Cancer Journal
-
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
Nature Communications
-
Bright and stable luminescent probes for target engagement profiling in live cells
Nature Chemical Biology
-
The adaptive proline response in P. falciparum is independent of PfeIK1 and eIF2α signaling
ACS Infectious Diseases
-
Social Alarms and Reminders
United States Patent 10,382,613